REV1, a Y family DNA polymerase (pol), is involved in replicative bypass past DNA lesions, so-called translesion DNA synthesis. In addition to a structural role as a scaffold protein, REV1 has been proposed to play a catalytic role as a dCTP transferase in translesion DNA synthesis past abasic and guanine lesions in eukaryotes. To better understand the catalytic function of REV1 in guanine lesion bypass, purified recombinant human REV1 was studied with two series of guanine lesions, N 2 -alkylG adducts (in oligonucleotides) ranging in size from methyl (Me) to CH 2 (6-benzo[a]pyrenyl) (BP) and O 6 -alkylG adducts ranging from Me to 4-oxo-4-(3-pyridyl)butyl (Pob). REV1 readily produced 1-base incorporation opposite G and all G adducts except for O 6 -PobG, which caused almost complete blockage. Steadystate kinetic parameters (k cat /K m ) were similar for insertion of dCTP opposite G and N 2 -G adducts but were severely reduced opposite the O 6 -G adducts. REV1 showed apparent pre-steadystate burst kinetics for dCTP incorporation only opposite N 2 -BPG and little, if any, opposite G, N 2 -benzyl (Bz)G, or O 6 -BzG. The maximal polymerization rate (k pol 0.9 s ؊1 ) opposite N 2 -BPG was almost the same as opposite G, with only slightly decreased binding affinity to dCTP (2.5-fold). REV1 bound N 2 -BPG-adducted DNA 3-fold more tightly than unmodified G-containing DNA. These results and the lack of an elemental effect ((S p )-2-deoxycytidine 5-O-(1-thiotriphosphate)) suggest that the late steps after product formation (possibly product release) become rate-limiting in catalysis opposite N 2 -BPG. We conclude that human REV1, apparently the slowest Y family polymerase, is kinetically highly tolerant to N 2 -adduct at G but not to O 6 -adducts.
be removed by versatile cellular repair systems, many DNA lesions escape repair and are usually present in replicating DNA. Facing DNA lesions during DNA replication, DNA polymerases often show unusual behavior, such as misinsertion, slippage, and blockage, which can give rise to mutations or cell death (1) . Therefore, the characterization of interaction of DNA polymerases with DNA lesions is crucial for understanding the mechanism of mutagenesis in cells in detail (2) . Human cells possess at least 15 different DNA polymerases, the physiological functions of most of which are still unclear. Replicative DNA polymerases, such as pol 2 ␣, ␦, and ⑀, are intolerant of DNA distortions caused by many DNA lesions and thus are blocked (3) . As a tolerance mechanism to this replication blockade, cells utilize the specialized translesion synthesis (TLS) DNA polymerases, which have a spacious active site to replicate past replication fork-blocking lesions (4) . Many of human TLS DNA polymerases belong to the recently discovered Y family, including pol , pol , pol , and REV1 (5) . Y family members often have different properties of bypass ability and fidelity opposite various DNA lesions (4) .
The N2 and O6 atoms at G are highly susceptible to modification by various potential carcinogens. The N2 atom of G is easily modified by formaldehyde (6) , acetaldehyde (7) , and the oxidation products of heterocyclic amines (e.g. 2-amino-3-methylimidazo [4,5-f] quinoline (8) ) and polycyclic aromatic hydrocarbons (e.g. benzo[a]pyrene (9)), forming various N 2 -G derivatives, such as Me, Et, 2-amino-3-methylimidazo [4,5-f] quinoline, and benzo[a]pyrene diol epoxide adducts. In a different way, the O6 atom of G is readily modified by DNA-alkylating agents (10, 11) and metabolites of tobacco-specific carcinogen 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (12) , forming various O 6 -G adducts, such as Me, Et, and 4-oxo-4-(3-pyridyl)butyl (Pob) adducts. Relatively large G adducts, such as N 2 -benzo[a]pyrene diol epoxide-G (13) and O 6 -PobG (14) produce mutations in bacterial and mammalian cells. Even small G adducts, such as N 2 -EtG and O 6 -EtG, also produce some mutations in bacterial and human cells (15, 16) but with varied spectra and frequencies. These diverse mutagenicities of G lesions may be attributable to the differences in translesion DNA synthesis for each. To better understand TLS processes at N 2 -and O
6
-G lesions and the mechanisms of mutagenesis, we have previously addressed the details of lesion bypass across various N 2 -G and O 6 -G adducts by DNA polymerases, including replicative polymerases, such as human immunodeficiency virus type 1 reverse transcriptase, pol T7
Ϫ (17) (18) (19) , and human pol ␦ and TLS polymerases, such as human pol , , and (20 -25) .
REV1, a Y family polymerase, is believed to play both structural and catalytic roles in TLS in eukaryotes. REV1 has been suggested to serve as a scaffold protein for the recruitment of polymerases by the ability of interactions with proteins PCNA (26) , ubiquitinated proteins (27) , and polymerases , , , and (28) . In its catalytic role as a polymerase, REV1 can catalyze the preferential insertion of dCTP opposite template G, apurinic/ apyrimidinic sites, and the various damaged bases (29 -33) by utilizing a unique mechanism of protein-template-directed nucleotide incorporation (34) , but the enzymatic role of REV1 in TLS still remains to be elucidated. With a unique ability for selective dCTP insertion, REV1 inherently has the potential to play a role in error-free bypass opposite guanine DNA lesions. Although the suggestion has been advanced that REV1 can incorporate dCTP opposite some minor groove guanine adducts and facilitate the lesion bypass (35) , quantitative evidence to support this suggestion is still limited.
In order to obtain a better understanding of the catalytic role of human REV1 in bypass of guanine lesions, we performed steady-state and pre-steady-state kinetic studies with this enzyme and site-specifically modified oligonucleotides containing various N 2 -G and O 6 -G adducts. The results obtained with REV1 can also be compared with the corresponding studies done with three other human Y family polymerases, pol (22) , pol (21) , and pol (20) . Our results indicate that REV1 catalysis is remarkably resistant to the large lesions at guanine N2, very similar to pol , but not at guanine O6. This study also provides detailed kinetic information on human REV1, which is quite different from other human Y family polymerases.
EXPERIMENTAL PROCEDURES
Materials-Unlabeled dNTPs, T4 polynucleotide kinase, and restriction endonucleases were purchased from New England Biolabs (Ipswich, MA). (S p )-dCTP␣S was purchased from Biolog Life Science Institute (Bremen, Germany). [␥-
32 P]ATP (specific activity 3,000 Ci/mmol) was purchased from PerkinElmer Life Sciences. Bio-spin columns were purchased from Bio-Rad. A protease inhibitor mixture was obtained from Roche Applied Science. Human testis cDNA was purchased from BD Biosciences Clontech. Pfu Ultra DNA polymerase and pPCR-Script Amp vector were purchased from Stratagene (La Jolla, CA). Amicon Ultra centrifugal filter devices were purchased from Millipore (Billerica, MA).
Oligonucleotides-Unmodified 24-and 36-mer (Table 1) were purchased from Midland Certified Reagent Co. (Midland, TX). Eleven 36-mers, each containing a guanine
-BzG, and O 6 -PobG) were prepared as previously described (17, (21) (22) (23) 2-kb coding region from the 5Ј-end and the 1.8-kb coding region from the 3Ј-end) from human testis cDNAs (as template) using Pfu Ultra DNA polymerase with the two sets of corresponding primers (5Ј-CATATGCATC-ACCATCACCATCACATGAGGCGAGGTGGATGG-3Ј and 5Ј-CTTCTGCCTCTTTTGGCTGAGT-3Ј for the 5Ј-end coding region of REV1; 5Ј-TTGTGGAGACTTGCAGTA-3Ј and 5Ј-CTCGAGTTATGTAACTTTTAATGTGC-3Ј for the 3Ј-end coding region of REV1). The resulting 2.2-and 1.8-kb PCR products of REV1 were cloned into the vector pPCR-Script Amp, respectively, and nucleotide sequencing was used to confirm the sequence of the coding region. The full-length human REV1 cDNA was constructed by ligating a 2.1-kb SmaI/BstBI fragment containing the 5Ј-fragment of hREV1 into the SmaI/ BstBI sites of the 4.6-kb pPCR-Script Amp vector containing 3Ј-fragment of hREV1. The 3.8-kb human REV1 cDNA fragment was then cloned into the NdeI and XhoI sites of the vector pET-22b(ϩ), generating pET22b(ϩ)/hREV1-NHis6 vector.
Expression and Purification of Human REV1-Recombinant human REV1, fused to an N-terminal His 6 tag, was expressed in E. coli strain BL21(DE3). E. coli BL21(DE3) harboring the vector (24 liters) was grown in Luria-Bertani broth supplemented with ampicillin (100 g ml Ϫ1 ) at 25°C, with aeration, to A 600 0.6. Isopropyl-␤-D-thiogalactopyranoside was added to 0.2 mM, and the incubation was continued for 11 h at 15°C. The cells were harvested by centrifugation and resuspended in 60 ml of lysis buffer (50 mM Tris-HCl, pH 7.4, containing 300 mM NaCl, 10% glycerol (v/v), 5 mM ␤-mercaptoethanol, 1 mg/ml lysozyme, and protease inhibitor mixture (Roche Applied Sciences), cooled on ice for 30 min, and then lysed by sonication (12 ϫ 10 s duration with a Branson digital sonifier (VWR, West Chester, PA), microtip, 45% amplitude, with intervening cooling time). The cell lysate was clarified by centrifugation at 4 ϫ 10 4 ϫ g for 60 min at 4°C. The resulting supernatant was loaded (0.3 ml min Ϫ1 ) onto a 5-ml size FPLC HisTrap HP column (Amersham Biosciences) at 4°C. The column was washed (at 0.8 ml min Ϫ1 ) with 50 ml of Buffer A (50 mM Tris-HCl, pH 7.5, with 500 mM NaCl, 10% glycerol (v/v), and 5 mM 2-mercaptoethanol) containing 20 mM imidazole, 50 ml of Buffer A containing 40 mM imidazole, and then with 50 ml of Buffer A containing 50 mM imidazole. Bound His 6 -tagged REV1 was eluted with 400 mM imidazole in Buffer B. Fractions containing REV1 were collected and diluted 2-fold with Buffer B (50 mM Tris- 
HCl (pH 7.5) containing 10% glycerol (v/v), 5 mM 2-mercaptoethanol, and 1 mM EDTA) and loaded onto a Mono Q column (Amersham Biosciences Bioscience). REV1 was eluted with a 50-ml linear gradient of 250 mM to 1 M NaCl in Buffer B. Eluted fractions (0.26 ml) were analyzed by SDS-polyacrylamide gel electrophoresis, and REV1 was found to be eluted at 320 mM NaCl. Fractions containing REV1 were collected and loaded onto a HiTrap Heparin HP column (Amersham Biosciences Bioscience). REV1 was eluted with a 50-ml linear gradient of 400 mM to 1 M NaCl in Buffer B. Eluted fractions (0.26 ml) were analyzed by SDS-polyacrylamide gel electrophoresis, and REV1 was found to be eluted at 700 mM NaCl. The pooled fractions containing REV1 were concentrated (using an Amicon Ultra centrifugal filter; Millipore) to a volume of 100 l and further purified using a Superdex 200 column (Amersham Biosciences) with buffer B containing 400 mM NaCl. Fractions containing recombinant protein were pooled, concentrated, and exchanged into storage buffer (50 mM Tris-HCl, pH 7.5, containing 50% glycerol (v/v), 5 mM 2-mercaptoethanol, 1 mM EDTA, and 400 mM NaCl). The yield was about 330 g from 24 liters of culture. The protein concentration was determined using a calculated ⑀ 280 value of 102 mM Ϫ1 cm Ϫ1 for REV1 (37) . An SDS-polyacrylamide gel electrophoretogram of purified REV1 is included in Fig. S1 .
Reaction Conditions for Enzyme Assays-Unless indicated otherwise, standard DNA polymerase reactions were performed in 50 mM Tris-HCl (pH 7.5) buffer containing 50 mM NaCl, 5 mM dithiothreitol, 100 g ml Ϫ1 bovine serum albumin (w/v), and 10% glycerol (v/v) with 100 nM primer-template at 37°C. Primers were 5Ј-end-labeled using T4 polynucleotide kinase with [␥-32 P]ATP and annealed with template (36-mer). All reactions were initiated by the addition of dNTP and MgCl 2 (5 mM final concentration) to preincubated enzyme/DNA mixtures.
Primer Extension Assay with All Four dNTPs-A 32 P-labeled primer, annealed to either an unmodified or adducted template, was extended in the presence of all four dNTPs (100 M each) for 15 min. Reaction mixtures (8 l) were quenched with 2 volumes of a solution of 20 mM EDTA in 95% formamide (v/v). Products were resolved using a 16% polyacrylamide (w/v) gel electrophoresis system containing 8 M urea and visualized using a Bio-Rad Molecular Imager FX and Quantity One software (Bio-Rad).
Steady-state Reactions-A 32 P-labeled primer, annealed to either an unmodified or adducted template, was extended in the presence of increasing concentrations of a single dNTP. The molar ratio of primer/template to enzyme was at least 10:1, except for dGTP, dTTP, and O 6 -PobG-adducted template. Enzyme concentrations and reaction times were chosen so that maximal product formation would be Յ20% of the substrate concentration (38) . The primer-template was extended with dNTP in the presence of 0.1-50 nM enzyme for 5 or 10 min. All reactions (8 l) were done at 10 dNTP concentrations and quenched with 10 volumes of a solution of 20 mM EDTA in 95% formamide (v/v). Products were resolved using a 16% polyacrylamide (w/v) electrophoresis gel containing 8 M urea and quantitated by phosphorimaging analysis using a Bio-Rad molecular imager FX instrument and Quantity One software. 
where k pol is the maximal rate of nucleotide incorporation, and K d dCTP is the equilibrium dissociation constant for dCTP (39, 40) .
Estimation of the Apparent Dissociation Constant (K d ) for DNA by Electrophoretic Mobility Shift
Assay-Increasing concentrations of human REV1 (2.5-320 nM) were incubated with 0.5 nM 32 P-labeled 24-mer/36-mer primer-template DNA on ice for 15 min in the binding buffer containing 50 mM Tris-HCl (pH 8.0 at 4°C), 50 mM NaCl, 50 mM MgCl 2 , 5 mM dithiothreitol, 100 g ml Ϫ1 bovine serum albumin (w/v), and 10% glycerol (v/v). The mixtures were directly loaded on nondenaturing 4% polyacrylamide gels and electrophoresed at 8 V cm Ϫ1 for 1 h at 4°C in the running buffer (40 mM Tris acetate (pH 8.0 at 4°C) containing 5 mM magnesium acetate and 0.1 mM EDTA. The fractions of REV1-bound DNA were quantitated using a BioRad molecular imager FX instrument and Quantity One software. Assuming a 1:1 stoichiometry between REV1 and DNA substrate, the data were fit to a single-site binding equation (41),
, where ϭ fraction saturation and [E f ] ϭ free enzyme concentration, in GraphPad Prism software. The free enzyme concentration was estimated using a conservation of REV1-catalyzed Pyrophosphorolysis-REV1 (50 nM) was preincubated with 100 nM 32 P-labeled 25-mer/36-mer primertemplate DNA in a reaction mixture containing 50 mM TrisHCl (pH 7.5), 50 mM NaCl, 50 mM MgCl 2 , 5 mM dithiothreitol, 100 g ml Ϫ1 bovine serum albumin (w/v), and 10% glycerol (v/v) on ice for 15 min. Pyrophosphorolysis was then initiated by the addition of various concentrations of PP i to a preincubated E⅐DNA mixture. After 15 min at 37°C, the reactions were quenched with 10 volumes of a solution of 20 mM EDTA in 95% formamide (v/v). Products were analyzed by electrophoresis, as described for the steady-state experiments. (Tables 2 and 3 ). The incorporations of dATP opposite G, N 2 -G, and O 6 -G adducts were not determined because of much less efficient activity than with other dNTPs. REV1 preferentially incorporated dCTP opposite G and all of the modified G adducts, with relatively low misinsertion frequency for dTTP and dGTP (f ϭ 0.006 -0.06), where
RESULTS

Primer Extension by
-modifications at G increased the misinsertion frequencies of dGTP and dTTP 1.1-9-fold. The increase in the misinsertion frequencies of dGTP and dTTP was highest (4-and 9-fold) with 6 -modified G placed at the 25th position from the 3Ј-end (see Fig. 1 ). Reactions were performed for 15 min with increasing concentrations of REV1 (0 -50 nM) and a constant concentration of DNA substrate (100 nM primer-template) as indicated. 32 PLabeled 24-mer primer was extended in the presence of all four dNTPs. The reaction products were analyzed by denaturing gel electrophoresis with subsequent phosphorimaging analysis.
O
6 -BzG and N 2 -AnthG, respectively, and was attributable to the decreased k cat /K m value for the correct dCTP insertion and the increased k cat /K m values of dGTP and dTTP insertion.
For the correct incorporation of dCTP, REV1 showed catalytic efficiencies (k cat /K m ) opposite N 2 -modified G adducts similar to unmodified G, whereas REV1 showed severely reduced catalytic efficiencies opposite O 6 -G adducts (e.g. 16-fold with O 6 -MeG and 6000-fold with O 6 -PobG). Notably, the value of k cat /K m with the N 2 -BPG template was nearly the same as that with the G template, although the values of K m and k cat with N 2 -BPG were both 6-fold lower than that with G. REV1 showed 6-fold greater catalytic efficiencies with N 2 -MeG and N 2 -BzG than those with O 6 -MeG and O 6 -BzG, respectively, indicating that the N 2 -G adduct is preferable to the O 6 -G adduct as a template base for polymerization by REV1. The large decrease (6000-fold) of k cat /K m for dCTP incorporation opposite O 6 -PobG was due to both the decrease of k cat and the increase of K m . Interestingly, REV1 also showed 4-fold greater catalytic efficiencies with the benzyl adducts at guanine N2 or O6 than the methyl adducts at the corresponding position, indicating that a larger but aromatic benzyl group adducted to guanine offers some advantage for REV1 polymerization over a smaller methyl group. For the incorrect dGTP and dTTP incorporations, REV1 showed much lower catalytic efficiencies (13-and 5- -BPG. The pre-steady-state burst rates of incorporation opposite N 2 -BPG were determined in a rapid quench instrument using dCTP and (S p )-dCTP␣S. Similar to a kinetic isotope effect, the sulfur substitution of ␣-oxygen at dCTP makes bond breakage more difficult. If the chemistry step is slow and rate-limiting in a reaction, the overall reaction should be slowed by dCTP␣S compared with dCTP (42) . Incorporation of (S p )-dCTP␣S opposite N 2 -BPG yielded no significant difference in the burst rate compared with dCTP (Fig. 4) , indicating that the chemistry step may not be rate-limiting in the polymerization cycle opposite N 2 -BPG.
Determination of K d dCTP for dCTP Incorporation by REV1-Analysis of the change of the pre-steady-state rate as a function of increasing dNTP concentration yields K d
dNTP , a measure of the binding affinity of the dNTP to the E⅐DNA binary complex to form a ternary complex poised for catalysis (39, 40 Ϫ and human immunodeficiency virus type 1 reverse transcriptase) (18, 43) , indicating that REV1 has a slightly higher binding affinity for dCTP opposite G than other Y family polymerases but much lower binding affinity than replicative polymerases.
Binding of REV1 to DNA Containing G and N 2 -BPG-An apparent dissociation constant (K d DNA ) of REV1 for primertemplate DNA substrate was estimated using an electrophoretic mobility shift assay. Electrophoretic mobility shift assays can provide some quantitative data for protein-nucleic acid binding, although it does not represent a true equilibrium constant (44) . The fraction of primer-template DNA shifted by REV1 was determined and used as an indicator for DNA binding of REV1. The data clearly indicate enhanced binding of the N 2 -BPG-DNA, as seen in the 40 and 80 nM REV1 lanes (Fig. 6, A and B) . The K d value of REV1 for unmodified DNA (24-mer/36-G-mer) was 180 Ϯ 8 nM, which was about 3-fold higher than that for N 2 -BPG-adducted DNA (24-mer/36-N 2 -BPG-mer) (Fig. 6C) , indicating that the binding affinity of DNA to REV1 is significantly increased by the presence of N 2 -BPG adduct. Pyrophosphorolysis on 25-Mer/36-Mer-The pyrophosphorolysis activity of REV1 (i.e. reversal of the polymerization reaction) was measured with 25-C-mer/36-G (or N 2 -G-adduct)-mer primer-template complexes in the presence of PP i . Dpo4, a Y family DNA polymerase from Sulfolobus solfataricus, has robust pyrophosphorolysis activity, which may possibly affect its fidelity, but human pol , , and do not (45) . Human REV1 (50 nM) showed only trace degradation (1-2%) of 25-mer primer even in the presence of 0.5-2 mM PP i , which was similarly observed with G and bulky N 2 -G-adduct-containing DNA (Fig. S2) . These results indicate that REV1 has only minimal pyrophosphorolysis activity, which appears not to be changed by the presence of a bulky N 2 -G adduct. (Fig. 1) at position 25 of the template (Fig. 2A) . Increasing concentrations of REV1 were used in 15-min incubations with each of both primer-template complexes in the presence of all four dNTPs. REV1 showed similar one-base exten- 
Comparison of Primer Extension in the Presence of All Four dNTPs and Steady-state Kinetic
DISCUSSION
In this study, we provide kinetic evidence that REV1 is considerably more competent for dCTP incorporation opposite large N 2 -modified G lesions compared with O 6 -modified G lesions. We investigated the effect of adducts at guanine N2 and O6 atoms of a DNA substrate on the polymerization ability and the fidelity by REV1 using steady-state and pre-steady-state kinetic analyses. Although having the lowest maximal polymerization rate (k pol 0.9 s Ϫ1 ) opposite unmodified G among human Y family DNA polymerases, REV1 achieved the correct dCTP incorporation opposite all N 2 -G lesions (including the largest N 2 -BPG) with catalytic efficiency similar to that opposite the unmodified G. In contrast, the lesions at the G O6 atom noticeably attenuated the ability of dCTP incorporation opposite lesion by REV1, ultimately leading to the almost complete loss of the ability opposite O 6 -PobG. The presence of an apparent burst only with N 2 -BPG but little with G suggests that the late steps after product formation may be considerably slowed by a relatively large lesion (e.g. BP) at guanine N2 during catalysis (e.g. release of the oligonucleotide). No significant decrease of catalytic efficiency in polymerization opposite N 2 ,N 2 -diMeG was observed compared with N 2 -EtG ( Table 4 ), suggesting that REV1 does not require a hydrogen atom at guanine N2 for efficient polymerization, consistent with the use of the hydrogen bonding with a protein-template (Arg) instead of a guanine template (34) .
Comparisons of abilities and fidelities of REV1 to polymerize opposite N 2 -and O 6 -G adducts provide detailed information about catalytic behavior of REV1 opposite those guanine lesions. We performed the kinetic comparison according to the variable of adduct size at both guanine N2 and O6, as done previously with other DNA polymerases (17, 20 -23) . Our approach using two series of N 2 -and O 6 -G adducts has an inherent limitation in that the chemical substitution at the N2 or O6 atom can change not only the size but also the other chemical properties, such as hydrophobic and electronic factors. For example, the hydrophobicity of guanine adducts grad- ually increases along with the steric bulk (alkyl and alkaryl group) in these series, but we cannot separate these effects (21) . Nonetheless, the information is still useful in understanding how different DNA polymerases handle various DNA modifications during DNA synthesis (17, 20 -23) . A plot of the catalytic specificity constants (k cat /K m ) versus the molecular volume of the substituent at the guanine N2 or O6 atom (Fig. 7A) indicates that REV1 is remarkably tolerant of relatively large lesions at guanine N2 compared with guanine O6. Although this catalytic feature has some similarity with other Y family DNA polymerases, REV1 is apparently the most resilient in catalysis against the larger adducts at guanine N2 among these four Y family DNA polymerases (Fig. 7, A-D) . We found that the k cat /K m values for dCTP incorporation opposite various N 2 -G adducts by REV1 are very similar to that opposite unmodified G in steady-state kinetics (Table 2) . Even the largest, N 2 -BPG, did not significantly decrease k cat /K m for dCTP incorporation. This pattern is compatible with pre-steady-state kinetic results (Fig. 3) in that REV1 incorporated dCTP opposite N 2 -BPG at the maximal rate of polymerization (k pol ) nearly the same as opposite unmodified G, despite the slight decrease in binding affinity of dCTP (Fig. 5) . Thus, none of the factors of N2 substitution at guanine appears to hinder the catalysis of REV1 much. In contrast, the bulky modifications at template guanine O6 severely decreased the k cat /K m for dCTP incorporation by REV1 (up to 6,000-fold), compared with the unmodified G (Table 3) . Thus, the large Pob group at guanine O6 almost abolished the catalytic activity of REV1 in the standing start primer extension (Fig. 2B) (Table 2 and 3), consistent with a catalytic role mainly as a dCTP transferase. However, although the initial recognition of dCTP is by an arginine, REV1 catalysis can be slowed by a large lesion.
The pre-steady-state kinetic analysis indicated a lack of burst kinetics in the incorporation of dCTP opposite G (Fig. 3A) . With the O 6 -substituted G adducts (Fig. 3B) , substitution slowed the rate but had no effect on the shape of the time course. However, increasing bulk (or, alternatively, hydrophobicity or aromaticity) at the N2 atom produced a trend with an increasing burst pattern (Fig. 3A) . The apparent burst (finished in ϳ1 s) amplitude only accounted for ϳ5% of that corresponding to one molecule of product formed by one REV1 protein (REV1 quantified by UV) in the case of REV1. The k pol was estimated to be ϳ1 s
Ϫ1
, consistent with single-turnover studies in which a similar k pol was estimated for dCTP insertion opposite G or N 2 -BPG (Fig.  5) . The kinetics of dCTP insertion opposite N 2 -BPG were not affected by the sulfur-substituted (S p )-dCTP␣S (Fig. 4) . These results are consistent with a step following product formation being rate-limiting only in the case of the bulky N 2 -substituted G template. This step could be product release, in that electrophoretic mobility shift experiments indicated 3-fold tighter binding of REV1 to the N 2 -BPG-containing DNA than the unmodified DNA (Fig. 6) , and this result may be congruent with a 5-fold decrease in k ss (Fig. 3A) . The lack of change in the ratio k cat /K m with increasing bulk or hydrophobicity at the N2 atom would be consistent with the decreasing k cat (possibly decreasing k off for the product) and a decreasing K m (possibly decreasing K d ), although the exact interpretation of K m is not straightforward in these systems (46) .
An unexplained issue is why only partial bursts were seen with the N 2 -BPG-adducted oligonucleotide (Figs. 3A and 4) . One possible explanation is that the purified REV1 preparation is only partially active. An alternative explanation is one advanced for the action of some replicative DNA polymerases at some DNA adducts, namely that the burst represents the fraction of the ternary DNA-polymerase⅐dCTP complex existing in a conformationally active form for rapid insertion (Fig. 8 ) (47, 48) . Kinetic modeling can readily be done to obtain such fits to the data (47) , although in this case there are not enough independent boundaries to make the exercise very definitive. The lesions at guanine N2 in the DNA substrate only slightly affected the affinity for the correct dCTP of REV1. We found only a 2.5-fold change in the K d dCTP for insertion opposite G and N 2 -BPG in a detailed kinetic analysis under apparent single-turnover conditions (Fig. 5 ). This small effect was also similarly observed in the previous report of pol with Which steps of the catalytic cycle in the kinetic scheme of REV1 (Fig. 8) can be affected by the lesions at guanine N2?
The same maximal polymerization rates opposite G and N 2 -BPG, the slight decrease of K d dCTP by N 2 -BPG, and no significant elemental effect with (S p )-dCTP␣S on polymerization for N 2 -BPG suggest that the steps for product formation (e.g. the formation of phosphodiester bond) (Fig. 8, step  4) , the conformational change (step 3), and dNTP binding (step 2) were not largely interfered with by N 2 -BPG. The contribution of reverse polymerization by REV1 also appears to be almost negligible from C:G and C:N 2 -G adducts in that pyrophosphorolysis was only minimal even at high concentrations of PP i (Fig. S2) . Although the elemental effects by dNTP␣S are not without controversy regarding interpretation due to the varied transition states among different polymerases (42), the existence of major differences in these values among polymerases and specific DNA adducts argues that they should be considered carefully. Interesting results were obtained in the experiments of pre-steady-state burst kinetics for dCTP incorporation opposite G and N 2 -G adducts. No apparent burst with unmodified G suggests that steps preceding the chemistry step (e.g. the conformational change) might be rate-limiting for polymerization opposite unmodified G. However, the appearance of a burst with the N 2 -BPG and the higher binding affinity of REV1 to N 2 -BPGcontaining DNA suggest that the late steps after the chemistry step, possibly product release (step 7), might be largely affected by N 2 -BPG and thus become at least partially ratelimiting in the overall catalysis. One possibility is that slowed REV1 release after the product formation opposite N 2 -BPG might provide a time interval sufficient for switching of REV1 to the other extender polymerases (e.g. pol and ) efficient for the subsequent extension in TLS events. We note a very recent report on pre-steady-state kinetics by yeast Rev1 protein, concluding that the nucleotide binding step can be interfered with during dCTP incorporation opposite nonguanine templates (49) . However, the k pol estimated in that work was only 0.012 s Ϫ1 , and the experiments do not appear to involve true pre-steady-state conditions.
The data collection for recombinant human pols , , , and REV1 now allows several comparisons among human Y family DNA polymerases (20 -23) . The major difference between Y family polymerases is in the rates of polymerization (i.e. k pol ). The k pol (or at least k p ) with REV1 (0.9 s Ϫ1 ) is much less than for pols , , and (40, 4, and 13 s Ϫ1 , respectively) for dCTP incorporation opposite unmodified G. But for the large N 2 -G adducts, the k pol with REV1 (0.9 s Ϫ1 with N 2 -BPG) is relatively higher than for pol (0.24 s Ϫ1 with N 2 -BPG) and pol (0.16 s Ϫ1 with N 2 -AnthG) although less than pol (5.9 s Ϫ1 with N 2 -BPG), indicating that REV1 has a relatively proficient catalytic ability for the accurate synthesis opposite large N 2 -G adducts, similar to pol . However, REV1 has no ability as a proficient extender past the lesion, unlike pol , and thus REV1 could be replaced by other extender polymerases for the rest of the lesion bypass process. In the analyses of the effects of guanine adducts on k cat /K m for dCTP incorporation with Y family pols, the effect of substitution at the O6 atom, especially with O 6 -PobG, is generally much more severe than that seen at N2 (Fig. 7) . With pol and REV1, however, no or only a low effect is found for relatively small O 6 -adducts, such as O 6 -MeG or O 6 -BzG, compared with pols and (Fig. 7, A and B) . These results can be partially explained by base-pairing modes and the structures in the active site of each polymerase. For pols and , which require Watson-Crick base pairing for efficient catalysis (50, 51) , dCTP is more efficiently incorporated opposite N 2 -G adducts than O 6 -G adducts, because optimal Watson-Crick hydrogen bonding is possible only with N 2 -G adducts but not with O 6 -G adducts. This view would be consistent with recent reports that the S. solfataricus Y family DNA polymerase Dpo4 forms a wobble base pair between C and O 6 -MeG (or O 6 -BzG), and thus the polymerization is inhibited (52, 53 may uniquely utilize an Arg for the optimal hydrogen bonding with an incoming dCTP, as shown with yeast Rev1 (34) . The Hoogsteen edge of template G forms hydrogen bonds with the G loop residues of REV1, and thus the relatively large lesion O 6 -PobG (but not O 6 -MeG or O 6 -BzG), might sterically clash with the G-loop of REV1 to interfere with catalysis (compared with N 2 -adducts, which are sterically unhindered) (34). However we cannot exclude the possibility that other chemical properties, such as increased hydrogen bonding capability of a Pob group (via pyridyl ring and carbonyl oxygen) or aromaticity of a B[a]P group, interfere with or facilitate the catalysis opposite guanine lesions by interactions with REV1 and DNA. Dispensability of the WatsonCrick hydrogen bonding between template G and dCTP might enable REV1 to retain an intrinsic ability for efficient and accurate bypass opposite specific guanine lesions that can mask the Watson-Crick face but not Hoogsteen edge (e.g. ring-closed 1,N 2 -etheno-G, malondialdehyde-G, and bulky C 8 -G adducts). Thus, detailed kinetic analyses for testing this hypothesis are possible. Consistent with this view, a very recent crystallographic report demonstrates that yeast Rev1 accommodates the exocyclic 1,N 2 -propano-dG adduct well in the active site (55) .
In conclusion, our results suggest that, among Y family DNA polymerases, human REV1 is very tolerant of bulky lesions at guanine N2 (least up to N 2 -BPG) for catalysis but poorly at guanine O6. The unique ability of REV1 for highly selective dCTP incorporation opposite various N 2 -and O 6 -guanine adducts also suggests that REV1 may play a catalytic role in an error-free bypass opposite certain types of guanine DNA lesions.
